Overview

A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Status:
Not yet recruiting
Trial end date:
2022-12-06
Target enrollment:
Participant gender:
Summary
A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical